San Francisco, CA
Coral develops new clinical tests to help providers streamline prior authorization and select the effective medication for a particular patient focusing on autoimmune conditions such as Inflammatory Bowel Disease and Rheumatoid Arthritis. It has also identified a unique population of non-responder patients and is working with drug developers to address this unmet medical need.
https://www.coralgenomics.com/These are collections Coral Genomics is a part of. Click on the collection name to view similar companies.
Grant
$1,700,000
Grant
$2,000,000
Seed
$2,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Coral Genomics.